1022403

Homayoon (nmi) Khanlou, M.D. — FEI 3006760992

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Beverly Hills, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance